4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001104659-23-130042
Director sold 1,390 shares at $10.90 ($15,151)
- Director acquired 3,144 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RALLIS CHRIS A Director | 2023-12-26 | Sale 10b5-1 | −1,390 | $10.90 | $15,151 | 44,788 | D |
| RALLIS CHRIS A Director | 2023-12-26 | Option exercise 10b5-1 | +3,144 | $1.59 | $4,999 | 46,178 | D |
| Derivatives | |||||||
| RALLIS CHRIS A Director | 2023-12-26 | Option exercise · Common Shares 10b5-1 | −3,144 | $1.59 | $4,999 | 184,168 | D |
| Open-market sales · 1,390 sh · avg $10.90 · $15,151 | |||||||
Loading xslF345X05/tm2333865-1_4seq1.xml…